Otros idiomas Mersana Therapeutics, Inc.

Acciones

MRSN

US59045L1061

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/06/2024			Varia. Cinco días.	Varia. 1 de enero.
2,02 ^USD	-3,81 %		-0,98 %	-12,93 %

12/06	Transcript : Mersana Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:00 AM
09/05	Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Mersana Therapeutics, Inc.(NasdaqGS:MRSN) dropped from S&P Biotechnology Select Industry Index	24/06
Mersana Therapeutics to Present at Upcoming Investor Conferences	22/05
Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M	09/05
Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results	09/05
Mersana Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/05
Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024	02/05
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	04/04
North American Morning Briefing : Markets on Hold -2-	20/03
Mersana Therapeutics, Inc.(NasdaqGS:MRSN) added to S&P Biotechnology Select Industry Index	18/03
Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q4 Revenue $10.7M, vs. Street Est of $14.8M	28/02
Mersana Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results	28/02
Mersana Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Mersana Therapeutics to Present at Upcoming Investor Conferences	27/02
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024	21/02
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference	01/02
Mersana Therapeutics Gears Up for Milestones in Cancer Drug Trials	05/01
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation at the 42nd Annual J.P. Morgan Healthcare Conference	05/01
Mersana Therapeutics, Inc. Announces Business Updates	05/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Mersana Therapeutics, Inc.

Acciones

MRSN

US59045L1061

Otros idiomas

Filtros